Angella N.

Angella N. is an experienced professional in quality control and virology, currently serving as the Quality Control Corporate Manager at Cellectis since March 2020, focusing on the improvement and implementation of control strategies for UCART cells and developing analytical methods for clinical GMP products. Prior to this role, Angella worked as a Quality Control Manager at Pherecydes Pharma, where responsibilities included establishing a QC department for bacteriophage production. Previous positions include a Biochemist Engineer at Eurofins Biopharma Product Testing and a Scientific Project Manager at Sanofi Pasteur, where Angella managed optimization projects for virological and immunological methods. Angella’s early academic career involved PhD studies at the French National Institute for Agricultural Research and ANSES, with a focus on recombinant viruses and immunization experiments. Angella holds a Doctorate in Virology from Université Paris Cité and a Master's degree in Microbiology from Paris-Sud University.